SuperPowerful Man tablets
The Therapeutic Goods Administration (TGA) advises that the product marketed as Chao Jimengnan 'SuperPowerful Man' tablets poses a potentially serious health risk to consumers.
TGA laboratory analysis has detected the presence of the prescription-only ingredients sulfosildenafil and tadalafil. The amounts of the prescription-only ingredients are significant and may cause severe side effects.
People who take 'SuperPowerful Man' tablets may have a drop in their blood pressure, which may cause:
These effects may be greater in those consumers taking medication for:
- high blood pressure
- pulmonary artery hypertension, or
- those taking Viagra or Viagra-like products
Consequently, the TGA has ordered the supplier of this product in Australia, JT Publishing Australia Pty Ltd, to recall this medicine from the Australian market.
If you have any of these tablets you should not take them. If you know anyone who has bought these tablets, please tell them about this alert.
If you have any concerns about the effects you have experienced with this product please contact a health professional immediately.
Compounds similar to sulfosildenafil and tadalafil are the active ingredients found in Viagra, Revatio and Cialis.
Products should be returned to the distributor
JT Publishing (Hustler Australia)
2-25 Alfred Road, Chipping North, NSW 2170.
Telephone: 02 9724 6622
The product has been imported into Australia and distributed by the company JT Publishing Australia Pty Ltd of Chipping Norton, NSW.
The product's labelling describes the product as a 'Natural Health Product for Enhancing Sexual Vitality'. The ingredients sulfosildenafil and tadalafil are not included on the product label.
This medicine has not been assessed by the TGA for quality, safety or efficacy and contains prescription-only ingredients. This product is not included on the Australian Register of Therapeutic Goods, which is a legal requirement for any therapeutic good being sold in Australia.
Reporting a problem
Information on how to report a suspected problem with a medicine or medical device to the TGA can be found at 'Report a problem with a therapeutic product'.